Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Traws Pharma, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −17 vs. Q2 2024
- Shares held
- 646.4K
- +535.0K (+480.3%) vs. Q2 2024Converted for a 1-for-25 split
- Total value
- $3.80M
- +$2.56M (+205.5%) vs. Q2 2024
- New holders
- 2
- 3 more added
- Sold out
- 19
- 5 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $5.19M |
| Q1 2026 | 28 | $6.62M |
| Q4 2025 | 22 | $3.86M |
| Q3 2025 | 18 | $2.41M |
| Q2 2025 | 19 | $1.87M |
| Q1 2025 | 19 | $3.98M |
| Q4 2024 | 19 | $10.2M |
| Q3 2024 | 12 | $3.80M |
| Q2 2024 | 30 | $1.36M |
| Q1 2024 | 26 | $1.88M |
| Q4 2023 | 27 | $1.35M |
| Q3 2023 | 28 | $1.27M |
| Q2 2023 | 24 | $2.19M |
| Q1 2023 | 25 | $1.04M |
| Q4 2022 | 29 | $1.01M |
| Q3 2022 | 30 | $1.54M |
| Q2 2022 | 32 | $2.36M |
| Q1 2022 | 28 | $3.60M |
| Q4 2021 | 34 | $6.14M |
| Q3 2021 | 37 | $10.5M |
| Q2 2021 | 24 | $10.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Traws Pharma, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 605,531 | $3.56M | 0.07% | +563,721+1,348.3% | AddedConverted for a 1-for-25 split |
| Vanguard Group Inc | 26,722 | $157.1K | 0.00% | −1,555−5.5% | ReducedConverted for a 1-for-25 split |
| BlackRock, Inc. | 9,956 | $58.5K | 0.00% | +9,956 | New |
| Bank of America Corp | 2,138 | $12.6K | 0.00% | +2,130+25,474.2% | AddedConverted for a 1-for-25 split |
| Morgan Stanley | 729 | $4.29K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| UBS Group AG | 630 | $3.70K | 0.00% | −3,313−84.0% | ReducedConverted for a 1-for-25 split |
| Tower Research Capital LLC (TRC) | 379 | $2.23K | 0.00% | +239+170.1% | AddedConverted for a 1-for-25 split |
| Vermillion & White Wealth Management Group, LLC | 205 | $1.21K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Group One Trading, L.P. | 64 | $376 | 0.00% | −1−0.8% | ReducedConverted for a 1-for-25 split |
| Danske Bank A/S | 7 | $41 | 0.00% | +7 | New |
| Pacific Capital Wealth Advisors, Inc | 2 | $12 | 0.00% | −1−24.2% | ReducedConverted for a 1-for-25 split |
| Cornerstone Planning Group LLC | 1 | $5 | 0.00% | −0−24.2% | ReducedConverted for a 1-for-25 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −8,963−100.0% | Sold outConverted for a 1-for-25 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −8,724−100.0% | Sold outConverted for a 1-for-25 split |
| Marex Group plc | 0 | $0 | 0.00% | −5,921−100.0% | Sold outConverted for a 1-for-25 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −4,840−100.0% | Sold outConverted for a 1-for-25 split |
| State Street Corp | 0 | $0 | 0.00% | −2,404−100.0% | Sold outConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,226−100.0% | Sold outConverted for a 1-for-25 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −1,094−100.0% | Sold outConverted for a 1-for-25 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −1,002−100.0% | Sold outConverted for a 1-for-25 split |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −562−100.0% | Sold outConverted for a 1-for-25 split |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −509−100.0% | Sold outConverted for a 1-for-25 split |
| Mutual Advisors, LLC | 0 | $0 | 0.00% | −508−100.0% | Sold outConverted for a 1-for-25 split |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −267−100.0% | Sold outConverted for a 1-for-25 split |
| Mather Group, LLC. | 0 | $0 | 0.00% | −96−100.0% | Sold outConverted for a 1-for-25 split |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold outConverted for a 1-for-25 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2−100.0% | Sold outConverted for a 1-for-25 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-25 split |
| FMR LLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-25 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-25 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −63−100.0% | Sold outConverted for a 1-for-25 split |
| BlackRock Inc. | – | – | – | – | Not filed |